Age Related Macular Degeneration Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Wet AMD
1.2.3 Dry AMD
1.3 Market by Application
1.3.1 Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Men
1.3.3 Woman
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Age Related Macular Degeneration (AMD) Market Perspective (2017-2028)
2.2 Age Related Macular Degeneration (AMD) Growth Trends by Region
2.2.1 Age Related Macular Degeneration (AMD) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Age Related Macular Degeneration (AMD) Historic Market Size by Region (2017-2022)
2.2.3 Age Related Macular Degeneration (AMD) Forecasted Market Size by Region (2023-2028)
2.3 Age Related Macular Degeneration (AMD) Market Dynamics
2.3.1 Age Related Macular Degeneration (AMD) Industry Trends
2.3.2 Age Related Macular Degeneration (AMD) Market Drivers
2.3.3 Age Related Macular Degeneration (AMD) Market Challenges
2.3.4 Age Related Macular Degeneration (AMD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Age Related Macular Degeneration (AMD) Players by Revenue
3.1.1 Global Top Age Related Macular Degeneration (AMD) Players by Revenue (2017-2022)
3.1.2 Global Age Related Macular Degeneration (AMD) Revenue Market Share by Players (2017-2022)
3.2 Global Age Related Macular Degeneration (AMD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Age Related Macular Degeneration (AMD) Revenue
3.4 Global Age Related Macular Degeneration (AMD) Market Concentration Ratio
3.4.1 Global Age Related Macular Degeneration (AMD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Age Related Macular Degeneration (AMD) Revenue in 2021
3.5 Age Related Macular Degeneration (AMD) Key Players Head office and Area Served
3.6 Key Players Age Related Macular Degeneration (AMD) Product Solution and Service
3.7 Date of Enter into Age Related Macular Degeneration (AMD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Age Related Macular Degeneration (AMD) Breakdown Data by Type
4.1 Global Age Related Macular Degeneration (AMD) Historic Market Size by Type (2017-2022)
4.2 Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2023-2028)
5 Age Related Macular Degeneration (AMD) Breakdown Data by Application
5.1 Global Age Related Macular Degeneration (AMD) Historic Market Size by Application (2017-2022)
5.2 Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Age Related Macular Degeneration (AMD) Market Size (2017-2028)
6.2 North America Age Related Macular Degeneration (AMD) Market Size by Type
6.2.1 North America Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022)
6.2.2 North America Age Related Macular Degeneration (AMD) Market Size by Type (2023-2028)
6.2.3 North America Age Related Macular Degeneration (AMD) Market Share by Type (2017-2028)
6.3 North America Age Related Macular Degeneration (AMD) Market Size by Application
6.3.1 North America Age Related Macular Degeneration (AMD) Market Size by Application (2017-2022)
6.3.2 North America Age Related Macular Degeneration (AMD) Market Size by Application (2023-2028)
6.3.3 North America Age Related Macular Degeneration (AMD) Market Share by Application (2017-2028)
6.4 North America Age Related Macular Degeneration (AMD) Market Size by Country
6.4.1 North America Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022)
6.4.2 North America Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Age Related Macular Degeneration (AMD) Market Size (2017-2028)
7.2 Europe Age Related Macular Degeneration (AMD) Market Size by Type
7.2.1 Europe Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022)
7.2.2 Europe Age Related Macular Degeneration (AMD) Market Size by Type (2023-2028)
7.2.3 Europe Age Related Macular Degeneration (AMD) Market Share by Type (2017-2028)
7.3 Europe Age Related Macular Degeneration (AMD) Market Size by Application
7.3.1 Europe Age Related Macular Degeneration (AMD) Market Size by Application (2017-2022)
7.3.2 Europe Age Related Macular Degeneration (AMD) Market Size by Application (2023-2028)
7.3.3 Europe Age Related Macular Degeneration (AMD) Market Share by Application (2017-2028)
7.4 Europe Age Related Macular Degeneration (AMD) Market Size by Country
7.4.1 Europe Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022)
7.4.2 Europe Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size (2017-2028)
8.2 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Type
8.2.1 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Age Related Macular Degeneration (AMD) Market Share by Type (2017-2028)
8.3 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Application
8.3.1 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Age Related Macular Degeneration (AMD) Market Share by Application (2017-2028)
8.4 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Region
8.4.1 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Age Related Macular Degeneration (AMD) Market Size (2017-2028)
9.2 Latin America Age Related Macular Degeneration (AMD) Market Size by Type
9.2.1 Latin America Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022)
9.2.2 Latin America Age Related Macular Degeneration (AMD) Market Size by Type (2023-2028)
9.2.3 Latin America Age Related Macular Degeneration (AMD) Market Share by Type (2017-2028)
9.3 Latin America Age Related Macular Degeneration (AMD) Market Size by Application
9.3.1 Latin America Age Related Macular Degeneration (AMD) Market Size by Application (2017-2022)
9.3.2 Latin America Age Related Macular Degeneration (AMD) Market Size by Application (2023-2028)
9.3.3 Latin America Age Related Macular Degeneration (AMD) Market Share by Application (2017-2028)
9.4 Latin America Age Related Macular Degeneration (AMD) Market Size by Country
9.4.1 Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022)
9.4.2 Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size (2017-2028)
10.2 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Type
10.2.1 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Age Related Macular Degeneration (AMD) Market Share by Type (2017-2028)
10.3 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Application
10.3.1 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Age Related Macular Degeneration (AMD) Market Share by Application (2017-2028)
10.4 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country
10.4.1 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Age Related Macular Degeneration (AMD) Introduction
11.1.4 Bayer Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022)
11.1.5 Bayer Recent Developments
11.2 F. HoffmannLa Roche
11.2.1 F. HoffmannLa Roche Company Details
11.2.2 F. HoffmannLa Roche Business Overview
11.2.3 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Introduction
11.2.4 F. HoffmannLa Roche Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022)
11.2.5 F. HoffmannLa Roche Recent Developments
11.3 Regeneron
11.3.1 Regeneron Company Details
11.3.2 Regeneron Business Overview
11.3.3 Regeneron Age Related Macular Degeneration (AMD) Introduction
11.3.4 Regeneron Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022)
11.3.5 Regeneron Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Age Related Macular Degeneration (AMD) Introduction
11.4.4 Novartis Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022)
11.4.5 Novartis Recent Developments
11.5 Valeant
11.5.1 Valeant Company Details
11.5.2 Valeant Business Overview
11.5.3 Valeant Age Related Macular Degeneration (AMD) Introduction
11.5.4 Valeant Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022)
11.5.5 Valeant Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Age Related Macular Degeneration (AMD) Introduction
11.6.4 Pfizer Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022)
11.6.5 Pfizer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Wet AMD
Table 3. Key Players of Dry AMD
Table 4. Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Age Related Macular Degeneration (AMD) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Age Related Macular Degeneration (AMD) Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Age Related Macular Degeneration (AMD) Market Share by Region (2017-2022)
Table 8. Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Age Related Macular Degeneration (AMD) Market Share by Region (2023-2028)
Table 10. Age Related Macular Degeneration (AMD) Market Trends
Table 11. Age Related Macular Degeneration (AMD) Market Drivers
Table 12. Age Related Macular Degeneration (AMD) Market Challenges
Table 13. Age Related Macular Degeneration (AMD) Market Restraints
Table 14. Global Age Related Macular Degeneration (AMD) Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Age Related Macular Degeneration (AMD) Revenue Share by Players (2017-2022)
Table 16. Global Top Age Related Macular Degeneration (AMD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age Related Macular Degeneration (AMD) as of 2021)
Table 17. Ranking of Global Top Age Related Macular Degeneration (AMD) Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Age Related Macular Degeneration (AMD) Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Age Related Macular Degeneration (AMD) Product Solution and Service
Table 21. Date of Enter into Age Related Macular Degeneration (AMD) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2017-2022)
Table 25. Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2023-2028)
Table 27. Global Age Related Macular Degeneration (AMD) Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Age Related Macular Degeneration (AMD) Revenue Share by Application (2017-2022)
Table 29. Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Age Related Macular Degeneration (AMD) Revenue Share by Application (2023-2028)
Table 31. North America Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Age Related Macular Degeneration (AMD) Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Age Related Macular Degeneration (AMD) Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Age Related Macular Degeneration (AMD) Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Age Related Macular Degeneration (AMD) Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Age Related Macular Degeneration (AMD) Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Age Related Macular Degeneration (AMD) Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Age Related Macular Degeneration (AMD) Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Age Related Macular Degeneration (AMD) Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Age Related Macular Degeneration (AMD) Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Age Related Macular Degeneration (AMD) Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Age Related Macular Degeneration (AMD) Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Age Related Macular Degeneration (AMD) Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Age Related Macular Degeneration (AMD) Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Age Related Macular Degeneration (AMD) Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Age Related Macular Degeneration (AMD) Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Age Related Macular Degeneration (AMD) Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Age Related Macular Degeneration (AMD) Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Age Related Macular Degeneration (AMD) Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Age Related Macular Degeneration (AMD) Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Age Related Macular Degeneration (AMD) Market Size by Country (2023-2028) & (US$ Million)
Table 61. Bayer Company Details
Table 62. Bayer Business Overview
Table 63. Bayer Age Related Macular Degeneration (AMD) Product
Table 64. Bayer Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
Table 65. Bayer Recent Developments
Table 66. F. HoffmannLa Roche Company Details
Table 67. F. HoffmannLa Roche Business Overview
Table 68. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Product
Table 69. F. HoffmannLa Roche Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
Table 70. F. HoffmannLa Roche Recent Developments
Table 71. Regeneron Company Details
Table 72. Regeneron Business Overview
Table 73. Regeneron Age Related Macular Degeneration (AMD) Product
Table 74. Regeneron Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
Table 75. Regeneron Recent Developments
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis Age Related Macular Degeneration (AMD) Product
Table 79. Novartis Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
Table 80. Novartis Recent Developments
Table 81. Valeant Company Details
Table 82. Valeant Business Overview
Table 83. Valeant Age Related Macular Degeneration (AMD) Product
Table 84. Valeant Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
Table 85. Valeant Recent Developments
Table 86. Pfizer Company Details
Table 87. Pfizer Business Overview
Table 88. Pfizer Age Related Macular Degeneration (AMD) Product
Table 89. Pfizer Revenue in Age Related Macular Degeneration (AMD) Business (2017-2022) & (US$ Million)
Table 90. Pfizer Recent Developments
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Age Related Macular Degeneration (AMD) Market Share by Type: 2021 VS 2028
Figure 2. Wet AMD Features
Figure 3. Dry AMD Features
Figure 4. Global Age Related Macular Degeneration (AMD) Market Share by Application: 2021 VS 2028
Figure 5. Men Case Studies
Figure 6. Woman Case Studies
Figure 7. Age Related Macular Degeneration (AMD) Report Years Considered
Figure 8. Global Age Related Macular Degeneration (AMD) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Age Related Macular Degeneration (AMD) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Age Related Macular Degeneration (AMD) Market Share by Region: 2021 VS 2028
Figure 11. Global Age Related Macular Degeneration (AMD) Market Share by Players in 2021
Figure 12. Global Top Age Related Macular Degeneration (AMD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age Related Macular Degeneration (AMD) as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Age Related Macular Degeneration (AMD) Revenue in 2021
Figure 14. North America Age Related Macular Degeneration (AMD) Market Size YoY (2017-2028) & (US$ Million)
Figure 15. North America Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2017-2028)
Figure 16. North America Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2017-2028)
Figure 17. North America Age Related Macular Degeneration (AMD) Market Size Share by Country (2017-2028)
Figure 18. United States Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Age Related Macular Degeneration (AMD) Market Size YoY (2017-2028) & (US$ Million)
Figure 21. Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2017-2028)
Figure 22. Europe Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2017-2028)
Figure 23. Europe Age Related Macular Degeneration (AMD) Market Size Share by Country (2017-2028)
Figure 24. Germany Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Age Related Macular Degeneration (AMD) Market Size YoY (2017-2028) & (US$ Million)
Figure 31. Asia Pacific Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2017-2028)
Figure 32. Asia Pacific Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2017-2028)
Figure 33. Asia Pacific Age Related Macular Degeneration (AMD) Market Size Share by Region (2017-2028)
Figure 34. China Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 40. Latin America Age Related Macular Degeneration (AMD) Market Size YoY (2017-2028) & (US$ Million)
Figure 41. Latin America Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2017-2028)
Figure 42. Latin America Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2017-2028)
Figure 43. Latin America Age Related Macular Degeneration (AMD) Market Size Share by Country (2017-2028)
Figure 44. Mexico Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Middle East and Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2017-2028)
Figure 48. Middle East and Africa Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2017-2028)
Figure 49. Middle East and Africa Age Related Macular Degeneration (AMD) Market Size Share by Country (2017-2028)
Figure 50. Turkey Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. UAE Age Related Macular Degeneration (AMD) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Bayer Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2017-2022)
Figure 54. F. HoffmannLa Roche Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2017-2022)
Figure 55. Regeneron Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2017-2022)
Figure 56. Novartis Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2017-2022)
Figure 57. Valeant Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2017-2022)
Figure 58. Pfizer Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2017-2022)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Industry Market Size
